Biogenes Global is a holding company representing companies globally plugged into our vision of diagnostic simplified
Biogenes Technologies is incorporated in Malaysia with the 3 founders.
Licensed technology from Malaysian university, UKM on Arowana fish gender testing using DNA-based biosensor.
Biosensor technology breakthrough platform.
Began exploring aptamer-based technology for faster development of more diagnostic products.
Aptamer technology breakthrough ingredient design platform.
Covidsens - first diagnostics launched.
APTCAD aptamer design technology launched.
APTFAB foundry for biosensor launched.
APTSENS diagnostocs platform launched for digital diagnostics. New 10,000 sqft R&D facility launched. Biogenes hit milestone of 300 aptamers.
Launched two diagnostic products for local R&D outcomes; field test kit for paddy disease and aptamer-based HPV staining kit.
Biogenes Technologies Limited launched in the UK. Biogenes aims to seek out new opportunities, increase the use of platform technologies and build a global portfolio of Intellectual Properties.